Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.
暂无分享,去创建一个
L. Schneider | C. Lyketsos | P. Rabins | C. Meinert | J. Mintzer | D. Weintraub | C. Frangakis | P. Rosenberg | A. Porsteinsson | C. Munro | B. Martin | Lea T. Drye
[1] J. Morris,et al. Validity and Reliability of the Alzheimer's Disease Cooperative Study‐Clinical Global Impression of Change , 2017 .
[2] Constantine G Lyketsos,et al. Point and 5‐year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study , 2008, International journal of geriatric psychiatry.
[3] Charles E. Leonard,et al. Observed association between antidepressant use and pneumonia risk was confounded by comorbidity measures. , 2007, Journal of clinical epidemiology.
[4] M. Rapoport,et al. Efficacy and Safety of Antidepressants for Treatment of Depression in Alzheimer's Disease: A Metaanalysis , 2007, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[5] D. Beversdorf,et al. Long‐term effects of antidepressants on cognition in patients with Alzheimer's disease , 2006, Journal of clinical pharmacy and therapeutics.
[6] L. Schneider,et al. Design of Depression in Alzheimer's Disease Study-2. , 2006, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[7] P. Andersen,et al. Treatment with antidepressants in patients with dementia – a nationwide register-based study , 2006, International Psychogeriatrics.
[8] Marilyn S. Albert,et al. Research consent for cognitively impaired adults: recommendations for institutional review boards and investigators. , 2004, Alzheimer disease and associated disorders.
[9] C. Lyketsos,et al. The persistence of neuropsychiatric symptoms in dementia: the Cache County Study , 2004, International journal of geriatric psychiatry.
[10] Jason Brandt,et al. Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. , 2003, Archives of general psychiatry.
[11] M. Rubio,et al. Neumonía eosinófila aguda secundaria a la administración de sertralina , 2002 .
[12] Laura E. Gibbons,et al. Assessing Quality of Life in Older Adults With Cognitive Impairment , 2002, Psychosomatic medicine.
[13] J. Vilalta-Franch,et al. [Carer's burden and depressive symptoms in patients with Alzheimer s disease. State after twelve months]. , 2002, Revista de neurologia.
[14] B. Pollock,et al. Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. , 2002, The American journal of psychiatry.
[15] B. Lebowitz,et al. Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[16] B. Lebowitz,et al. Provisional diagnostic criteria for depression of Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[17] C. Lyketsos,et al. Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study , 2001, International journal of geriatric psychiatry.
[18] J. Steinberg,et al. Depression, cognitive impairment and function in Alzheimer's disease , 2001, International journal of geriatric psychiatry.
[19] S. Starkstein,et al. A Double-Blind, Placebo-Controlled Study of Fluoxetine in Depressed Patients With Alzheimer's Disease , 2001, International Psychogeriatrics.
[20] G. Kennedy,et al. A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease. , 2000, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[21] P. Rabins,et al. Concepts and methods in the development of the ADRQL: An instrument for assessing health-related quality of life in persons with Alzheimer's disease. , 1999 .
[22] D. Rubin. Multiple Imputation After 18+ Years , 1996 .
[23] M. Roth,et al. Moclobemide in Elderly Patients with Cognitive Decline and Depression: An International Double-blind, Placebo-controlled Trial , 1996, British Journal of Psychiatry.
[24] C. Gottfries,et al. The Clinical Efficacy of Citalopram in Treatment of Emotional Disturbances in Dementia Disorders a Nordic Multicentre Study , 1990, British Journal of Psychiatry.
[25] G. Alexopoulos,et al. Cornell scale for depression in dementia , 1988, Biological Psychiatry.
[26] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[27] M. Rubio,et al. [Acute eosinophilic pneumonia associated to sertraline]. , 2002, Medicina clinica.
[28] M. Sano,et al. An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimer's Disease , 1997, Alzheimer disease and associated disorders.
[29] J. Morris,et al. Validity and Reliability of the Alzheimer’s Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC) , 1997 .
[30] S H Ferris,et al. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. , 1997, Alzheimer disease and associated disorders.
[31] R. Leiguarda,et al. A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease. , 1996, The Journal of neuropsychiatry and clinical neurosciences.
[32] L. Teri,et al. Double-blind trial of imipramine in Alzheimer's disease patients with and without depression. , 1989, The American journal of psychiatry.